54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 06
00:29 UTC
|
KMB
Kimberly-Clark
|
◎ Target | Robert Moskow ★★★★☆ #388 | Hold | $96.00→ $104.00+8.3% |
|
Aug 06
00:29 UTC
|
KIDS
OrthoPediatrics
|
◎ Target | Mike Matson not yet tracked | Buy | $30.00→ $35.00+16.7% |
|
Aug 06
00:29 UTC
|
JXN
Jackson Financial
|
◎ Target | Ryan Krueger ★★★★★ #272 | Market Perform | $130.00→ $140.00+7.7% |
|
Aug 06
00:29 UTC
|
JELD
JELD-WEN
|
◎ Target | Matthew Bouley ★★★☆☆ #1427 | Equal Weight | $1.50→ $2.00+33.3% |
|
Aug 06
00:29 UTC
|
JELD
JELD-WEN
|
◎ Target | John Lovallo ★★★☆☆ #1823 | Neutral | $1.60→ $1.80+12.5% |
|
Aug 06
00:29 UTC
|
J
Jacobs Solutions
|
◎ Target | Sabahat Khan ★★★☆☆ #1613 | Outperform | $171.00→ $174.00+1.8% |
|
Aug 06
00:29 UTC
|
ITM
ITM Power
|
◎ Target | firm only | Neutral | GBX 60→ GBX 80+33.3% |
|
Aug 06
00:29 UTC
|
IT
Gartner
|
◎ Target | Jason Haas not yet tracked | Underweight | $120.00→ $150.00+25.0% |
|
Aug 06
00:29 UTC
|
IT
Gartner
|
◎ Target | Joshua Chan ★★★☆☆ #1306 | Neutral | $164.00→ $196.00+19.5% |
|
Aug 06
00:29 UTC
|
IT
Gartner
|
◎ Target | George Tong ★★★☆☆ #1046 | Neutral | $162.00→ $181.00+11.7% |
|
Aug 06
00:29 UTC
|
IT
Gartner
|
◎ Target | Ashish Sabadra ★★★★☆ #553 | Sec→ r Perform | $160.00→ $164.00+2.5% |
|
Aug 06
00:29 UTC
|
IRT
Independence Realty Trust
|
◎ Target | Brad Heffern ★★★★☆ #362 | Outperform | $18.00→ $19.00+5.6% |
|
Aug 06
00:29 UTC
|
INVH
Invitation Home
|
◎ Target | Jade Rahmani ★★★☆☆ #1742 | Market Perform | $29.00→ $31.00+6.9% |
|
Aug 06
00:29 UTC
|
INTA
Intapp
|
◎ Target | Terry Tillman ★★★★★ #297 | Buy | $35.00→ $45.00+28.6% |
|
Aug 06
00:29 UTC
|
INTA
Intapp
|
◎ Target | Patrick Moley ★★★☆☆ #1855 | Neutral | $25.00→ $34.00+36.0% |
|
Aug 06
00:29 UTC
|
INTA
Intapp
|
◎ Target | Saket Kalia ★★★★★ #168 | Underweight | $25.00→ $29.00+16.0% |
|
Aug 06
00:29 UTC
|
INGR
Ingredion
|
◎ Target | Joshua Spector ★★★☆☆ #1727 | Neutral | $104.00→ $108.00+3.8% |
|
Aug 06
00:29 UTC
|
INGR
Ingredion
|
◎ Target | Benjamin Theurer ★★★☆☆ #1183 | Equal Weight | $120.00→ $118.00-1.7% |
|
Aug 06
00:29 UTC
|
INDV
Indivior
|
◎ Target | Glen Santangelo ★★★★☆ #718 | Overweight | $46.00→ $43.00-6.5% |
|
Aug 06
00:29 UTC
|
IMO
Imperial Oil
|
◎ Target | firm only | Sec→ r Perform | C$214.00→ C$209.00-2.3% |
|
Aug 06
00:29 UTC
|
IMO
Imperial Oil
|
◎ Target | firm only | Sell | C$150.00→ C$151.00+0.7% |
|
Aug 06
00:29 UTC
|
IMO
Imperial Oil
|
◎ Target | firm only | Sec→ r Perform | C$159.00→ C$156.00-1.9% |
|
Aug 06
00:29 UTC
|
IDYA
IDEAYA Biosciences
|
◎ Target | Robert Driscoll ★★☆☆☆ #2344 | Outperform | $58.00→ $60.00+3.4% |
|
Aug 06
00:29 UTC
|
IDYA
IDEAYA Biosciences
|
◎ Target | Gregory Renza ★★★☆☆ #1227 | Buy | $63.00→ $59.00-6.3% |
|
Aug 06
00:29 UTC
|
IDXX
IDEXX Laboratories
|
◎ Target | Andrea Alfonso ★★★★☆ #619 | Neutral | $620.00→ $670.00+8.1% |
|
Aug 06
00:29 UTC
|
IDXX
IDEXX Laboratories
|
◎ Target | Daniel Grosslight ★★★★☆ #587 | Neutral | $650.00→ $670.00+3.1% |
|
Aug 06
00:29 UTC
|
IBTA
Ibotta
|
◎ Target | Chris Kuntarich ★★★☆☆ #1340 | Neutral | $30.00→ $38.00+26.7% |
|
Aug 06
00:29 UTC
|
IAG
iA Financial
|
◎ Target | firm only | Hold | C$214.00→ C$218.00+1.9% |
|
Aug 06
00:29 UTC
|
IAG
iA Financial
|
◎ Target | firm only | Sec→ r Perform | C$205.00→ C$216.00+5.4% |
|
Aug 06
00:29 UTC
|
HUT
Hut 8
|
◎ Target | John Todaro ★☆☆☆☆ #3213 | Buy | $145.00→ $138.00-4.8% |
|
Aug 06
00:29 UTC
|
HTH
Hilltop
|
◎ Target | Wood Lay ★★★★★ #213 | Market Perform | $40.00→ $42.00+5.0% |
|
Aug 06
00:29 UTC
|
HSBA
HSBC
|
◎ Target | firm only | Neutral | GBX 1,640→ GBX 1,570-4.3% |
|
Aug 06
00:29 UTC
|
HRMY
Harmony Biosciences
|
◎ Target | Danielle Brill ★★★☆☆ #2038 | Hold | $29.00→ $34.00+17.2% |
|
Aug 06
00:29 UTC
|
HNGE
Hinge Health
|
◎ Target | Rishi Jaluria ★★★☆☆ #1145 | Outperform | $75.00→ $110.00+46.7% |
|
Aug 06
00:29 UTC
|
HNGE
Hinge Health
|
◎ Target | Saket Kalia ★★★★★ #168 | Overweight | $97.00→ $100.00+3.1% |
|
Aug 06
00:29 UTC
|
HNGE
Hinge Health
|
◎ Target | Aaron Kimson ★★★★☆ #918 | Market Outperform | $96.00→ $107.00+11.5% |
|
Aug 06
00:29 UTC
|
HNGE
Hinge Health
|
◎ Target | Stan Berenshteyn ★★★★★ #317 | Overweight | $90.00→ $103.00+14.4% |
|
Aug 06
00:29 UTC
|
HNGE
Hinge Health
|
◎ Target | Ryan MacDonald ★★★★☆ #465 | Buy | $76.00→ $97.00+27.6% |
|
Aug 06
00:29 UTC
|
HMSO
Hammerson
|
◎ Target | firm only | Buy | GBX 385→ GBX 454+17.9% |
|
Aug 06
00:29 UTC
|
HLNE
Hamilton Lane
|
◎ Target | Chris Kotowski ★★★★☆ #684 | Outperform | $174.00→ $182.00+4.6% |
|
Aug 06
00:29 UTC
|
HLNE
Hamilton Lane
|
◎ Target | Michael Brown ★★★★☆ #466 | Buy | $114.00→ $131.00+14.9% |
|
Aug 06
00:29 UTC
|
HLNE
Hamilton Lane
|
◎ Target | Kyle Voigt ★★☆☆☆ #2540 | Outperform | $105.00→ $116.00+10.5% |
|
Aug 06
00:29 UTC
|
HLN
Haleon
|
◎ Target | firm only | Buy | GBX 512→ GBX 514+0.4% |
|
Aug 06
00:29 UTC
|
GWW
W.W. Grainger
|
◎ Target | Christopher Glynn ★★★☆☆ #1794 | Outperform | $1,350.00→ $1,375.00+1.9% |
|
Aug 06
00:29 UTC
|
GWW
W.W. Grainger
|
◎ Target | Deane Dray ★★★☆☆ #1828 | Sec→ r Perform | $1,460.00→ $1,428.00-2.2% |
|
Aug 06
00:29 UTC
|
GPOR
Gulfport Energy
|
◎ Target | Gabe Daoud not yet tracked | Hold | $190.00→ $186.00-2.1% |
|
Aug 06
00:29 UTC
|
GPOR
Gulfport Energy
|
◎ Target | Peyton Dorne ★★★★☆ #795 | Buy | $223.00→ $214.00-4.0% |
|
Aug 06
00:29 UTC
|
GPK
Graphic Packaging
|
◎ Target | Gabe Hajde not yet tracked | Underweight | $9.00→ $10.00+11.1% |
|
Aug 06
00:29 UTC
|
GLXY
Galaxy Digital
|
◎ Target | Gregory Lewis ★☆☆☆☆ #3072 | Buy | $50.00→ $45.00-10.0% |
|
Aug 06
00:29 UTC
|
GILD
Gilead Sciences
|
◎ Target | Brian Abrahams ★★★☆☆ #2227 | Sec→ r Perform | $120.00→ $123.00+2.5% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.